Expressions of Survivin and HIF-1α in breast cancer and their clinical significance

Chinese Journal of Cancer Prevention and Treatment

Volumn 15, Issue 10, 2008, Pages 765-768

  Chen, Jun ^a   Chen, Fa Long ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; DNA binding proteins; Immunohistochemistry; Microtubule associated proteins

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SURVIVIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST HYPERPLASIA; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 77953433308     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Semenza G L, Agani F, Booth G, et al. Structural and functional analysis of hypoxia inducible factor1[J]. Kidney Int, 1997, 51(2): 553-559.
2. Yeo E J, Chun Y S, Park J W. New anticancer strategies targeting HIF-1α. Biochem Pharmacol,2004,68(6):1061-1069.
3. Zaffaroni N, Pennati M, Daidonge M G. Survivin as a target for new anticancer interventions[J]. J Cell Mol Med,2005,9(2): 360-372.
4. Noriharu S, Toshimitsu U, Shigeyuki K, et al. Vascular endothelial growth factor and osteopontin in stage 1 lung adenocarcinoma[J]. Am J Respir Crit Care Med, 1999, 160(4): 1269-1273.
5. Deveraux Q L, Reed J C. IAP family proteins-suppressors of apoptosis[J]. Genes Dev, 1999, 13(3):239-252.
6. Lee G H, Joo Y E, Koh Y S, et al. Expression of survivin in gastric cancer and its relationship with rumor angiogenesis[J]. Eur J Gastroenterol Hepatol,2006,18(9):957-963.
7. Kishi H, Igawa M, Kikuno N, et al. Expression of the survivin gene in prostate cancer:correlation with clinicopathological characteristics, proliferative activity and apoptosis[J]. J Urol, 2004, 171(5):1855-1860.
8. Singh M, Bleile M J, Shroyer A J, et al. Analysis of survivin expression in a spect rum of benign to malignant lesions of the breast[J]. Appl Immunohistochem Mol Morphol, 2004,12(4): 296-304.
9. Chinese source.
10. Schindl M, Schoppmann S F, Samonigg H, et al. Over expression of hypoxia inducible factor 1 alpha is associated with an unfavorable prognosis in lymphnode positive breastcancer[J]. Clin Cancer Res,2002,8(6):1831-1837.
11. Chinese source.
12. Semenza G L. Targeting HIF-1 for cancer therapy[J]. Nat Rev Cancer,2003,3(10):721-732.
13. Greijer A E, Van der Wall E. The role of hypoxia inducible factor 1(HIF-1) in hypoxia induced apoptosis[J]. J Clin Pathol, 2004,57(10):1009-1014.
14. Chinese source.
15. Yang L, Cao Z, Li F, et al. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia[J]. Gene Ther,2004,11(15):1215-1223.